Vincent C.O. Njar

11.5k total citations
125 papers, 4.4k citations indexed

About

Vincent C.O. Njar is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vincent C.O. Njar has authored 125 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Molecular Biology, 53 papers in Genetics and 44 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vincent C.O. Njar's work include Estrogen and related hormone effects (53 papers), Prostate Cancer Treatment and Research (44 papers) and Hormonal and reproductive studies (21 papers). Vincent C.O. Njar is often cited by papers focused on Estrogen and related hormone effects (53 papers), Prostate Cancer Treatment and Research (44 papers) and Hormonal and reproductive studies (21 papers). Vincent C.O. Njar collaborates with scholars based in United States, United Kingdom and Germany. Vincent C.O. Njar's co-authors include Angela Brodie, Lalji K. Gediya, Robert D. Bruno, Tadas S. Vasaitis, Puranik Purushottamachar, A. Brodie, Senthilmurugan Ramalingam, Vidya P. Ramamurthy, Pankaj Chopra and Andrew K. Kwegyir‐Afful and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Cell and Cancer Research.

In The Last Decade

Vincent C.O. Njar

123 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent C.O. Njar United States 37 2.2k 1.3k 1.3k 787 771 125 4.4k
Angela Brodie United States 52 3.2k 1.4× 4.2k 3.1× 2.0k 1.6× 654 0.8× 1.4k 1.8× 132 7.8k
Atul Purohit United Kingdom 41 2.4k 1.1× 2.6k 1.9× 168 0.1× 1.4k 1.8× 738 1.0× 102 4.7k
Jun Sun United States 35 2.1k 0.9× 2.5k 1.8× 234 0.2× 690 0.9× 627 0.8× 80 5.1k
Scott W. Rowlinson United States 30 1.3k 0.6× 536 0.4× 391 0.3× 742 0.9× 454 0.6× 55 3.7k
Martin Rowlands United Kingdom 29 1.5k 0.7× 538 0.4× 301 0.2× 637 0.8× 266 0.3× 67 2.6k
Xiaolin Zi United States 39 2.9k 1.3× 176 0.1× 1.1k 0.8× 454 0.6× 388 0.5× 102 4.8k
Enrico Garattini Italy 48 3.9k 1.7× 675 0.5× 185 0.1× 233 0.3× 438 0.6× 158 5.5k
Robert W. Brueggemeier United States 34 1.6k 0.7× 1.9k 1.4× 162 0.1× 695 0.9× 259 0.3× 122 4.0k
Paula M. Loria United States 21 1.9k 0.8× 1.7k 1.3× 189 0.1× 374 0.5× 452 0.6× 35 3.5k
Gary A. Piazza United States 48 3.5k 1.5× 1.0k 0.8× 536 0.4× 1.2k 1.6× 138 0.2× 171 6.9k

Countries citing papers authored by Vincent C.O. Njar

Since Specialization
Citations

This map shows the geographic impact of Vincent C.O. Njar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent C.O. Njar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent C.O. Njar more than expected).

Fields of papers citing papers by Vincent C.O. Njar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent C.O. Njar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent C.O. Njar. The network helps show where Vincent C.O. Njar may publish in the future.

Co-authorship network of co-authors of Vincent C.O. Njar

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent C.O. Njar. A scholar is included among the top collaborators of Vincent C.O. Njar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent C.O. Njar. Vincent C.O. Njar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elbaz, Mohamad, Wiebke Schormann, Vincent C.O. Njar, et al.. (2024). Sterol-like drugs potentiate statin-triggered prostate cancer cell death by inhibiting SREBP2 nuclear translocation. Biomedicine & Pharmacotherapy. 177. 116934–116934. 2 indexed citations
2.
3.
4.
Thomas, Elizabeth, et al.. (2021). Abstract LBA027: Mechanistic insights on the effects of the lead next generation galeterone analog, VNPP433-3β in castration resistant prostate cancer. Molecular Cancer Therapeutics. 20(12_Supplement). LBA027–LBA027. 3 indexed citations
5.
6.
Purushottamachar, Puranik, et al.. (2012). Autophagy Inhibition Synergistically Enhances Anticancer Efficacy of RAMBA, VN/12-1 in SKBR-3 Cells, and Tumor Xenografts. Molecular Cancer Therapeutics. 11(4). 898–908. 16 indexed citations
7.
Purushottamachar, Puranik, et al.. (2012). Murine toxicology and pharmacokinetics evaluation of retinoic acid metabolism blocking agent (RAMBA), VN/12-1. Cancer Chemotherapy and Pharmacology. 70(2). 339–344. 2 indexed citations
8.
Moreira, Vânia M., Jorge A. R. Salvador, Α. Matos Beja, et al.. (2011). C16 and C17-heterocycle bearing androstanes. CYP17 inhibition studies and multiple effects on prostate cancer cells. European Journal of Pharmaceutical Sciences. 44. 2 indexed citations
9.
Gediya, Lalji K. & Vincent C.O. Njar. (2009). Promise and challenges in drug discovery and development of hybrid anticancer drugs. Expert Opinion on Drug Discovery. 4(11). 1099–1111. 193 indexed citations
10.
Sukumar, Saraswati, Zaver M. Bhujwalla, Angela Brodie, Vincent C.O. Njar, & Pedram Argani. (2008). Molecular studies of metastasis facilitated by a rapid autopsy program. Cancer Research. 68. 1 indexed citations
11.
Purushottamachar, Puranik, Aakanksha Khandelwal, Tadas S. Vasaitis, et al.. (2008). Potent anti-prostate cancer agents derived from a novel androgen receptor down-regulating agent. Bioorganic & Medicinal Chemistry. 16(7). 3519–3529. 26 indexed citations
12.
Shelton, Phillip M., Edward A. Sausville, Takeo Nakanishi, et al.. (2007). Breast cancer cells resistant to anti-hormone treatments retain sensitivity to Aminoflavone (NSC 686288). Molecular Cancer Therapeutics. 6. 3 indexed citations
13.
Bruno, Robert D. & Vincent C.O. Njar. (2007). Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development. Bioorganic & Medicinal Chemistry. 15(15). 5047–5060. 206 indexed citations
14.
15.
Corbin, C. Jo, Francisco Moran, Justin D. Vidal, et al.. (2003). Biochemical Assessment of Limits to Estrogen Synthesis in Porcine Follicles1. Biology of Reproduction. 69(2). 390–397. 39 indexed citations
16.
Nnane, Ivo, Vincent C.O. Njar, Yen‐Chin Liu, Qing‐Bin Lu, & A. Brodie. (1999). Effects of novel 17-azolyl compounds on androgen synthesis in vitro and in vivo. The Journal of Steroid Biochemistry and Molecular Biology. 71(3-4). 145–152. 18 indexed citations
17.
Njar, Vincent C.O., et al.. (1996). Synthesis of 10β-(1′-azirinyl)estr-4-en-3,17-dione as an aromatase inhibitor. Steroids. 61(3). 138–143. 8 indexed citations
18.
Njar, Vincent C.O., et al.. (1994). Antiulcer activity of the stem bark extract of Entandrophragma angolense. Phytotherapy Research. 8(1). 46–48. 6 indexed citations
19.
Njar, Vincent C.O., et al.. (1993). Novel 10β-aziridinyl steroids; inhibitors of aromatase. Journal of the Chemical Society Perkin Transactions 1. 1161–1168. 15 indexed citations
20.
Njar, Vincent C.O., et al.. (1993). 2-Methoxycanthin-6-one: A New Alkaloid from the Stem Wood ofQuassia amara. Planta Medica. 59(3). 259–261. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela Brodie Breakdown of academic impact, for papers by Atul Purohit Breakdown of academic impact, for papers by Jun Sun Breakdown of academic impact, for papers by Scott W. Rowlinson Breakdown of academic impact, for papers by Martin Rowlands Breakdown of academic impact, for papers by Xiaolin Zi Breakdown of academic impact, for papers by Enrico Garattini Breakdown of academic impact, for papers by Robert W. Brueggemeier Breakdown of academic impact, for papers by Paula M. Loria Breakdown of academic impact, for papers by Gary A. Piazza
Rankless by CCL
2026